CoChat

Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties

Buss, Joan L., Neuzil, Jiri, Gellert, Nina, Weber, Christian, Ponka, Prem · 2003 · Biochemical Pharmacology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Analogs of pyridoxal isonicotinoyl hydrazone (PIH) are of interest as iron chelators for the treatment of secondary iron overload and cancer. PIH, salicylaldehyde isonicotinoyl hydrazone (SIH), and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (NIH), the toxicity of which vary over two orders of magnitude, were selected for a study of their mechanisms of toxicity. PIH analogs and their iron complexes caused concentration- and time-dependent apoptosis in Jurkat T lymphocytes and K562 cells. Bcl-2 overexpression was partially anti-apoptotic, suggesting mitochondrial mediation of apoptosis. Since the pan-caspase inhibitor zVAD-fmk did not reduce lysosomal and mitochondrial destabilization, these events occur upstream of caspase activation. In contrast, phosphatidylserine externalization and the development of apoptotic morphology were inhibited significantly, indicating the role of caspases in mediating these later events. Since overexpression of CrmA had no effect on apoptosis, caspase-8 is not likely involved. Fe(3+) complexes of SIH and NIH, which accumulated in 59Fe-labeled mouse reticulocytes during incubation with the chelators, also caused apoptosis. BSA, which promotes release of the complexes from cells, reduced the toxicity of SIH and NIH, suggesting that the induction of apoptosis by PIH analogs involves toxic effects mediated by their Fe(3+) complexes. Moreover, analogs of these agents lacking the iron-chelating moiety were non-toxic.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0006-2952(02)01512-5

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Cited by

See all 42

Metadata

Authors
Buss, J. L., Neuzil, J., Gellert, N., Weber, C., & Ponka, P.
Affiliations
  • Jewish General Hospital (CA)
  • Ludwig-Maximilians-Universität München (DE)
  • Universitätsklinikum Aachen (DE)
Corresponding author
Ponka, Prem
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2003-01
Volume
65
Issue
2
Pages
161-172
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2068721397
Cited by
42
References
44
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 1 · 2013: 1 · 2012: 2
FWCI
0.81
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
  • Griffith Research Online (submittedVersion)
Funders
  • Cooley's Anemia Foundation
  • Canadian Institutes of Health Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
Keywords
pyridoxal isonicotinoyl hydrazone, iron chelation, apoptosis, salicylaldehyde isonicotinoyl hydrazone, iron(III) complexes, hematopoietic cells, Jurkat T lymphocytes, K562 cells, Bcl-2, mitochondrial apoptosis, caspase activation, phosphatidylserine exposure, secondary iron overload, cancer therapy, reticulocytes
MeSH terms
Ferric Compounds, Hematopoietic Stem Cells, Humans, Iron, Iron Chelating Agents, Isoniazid, Mitochondria, Pyridoxal, Reticulocytes, Apoptosis, Jurkat Cells, K562 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. https://app.cochat.ai/papers/10.1016/s0006-2952(02)01512-5
The paper
Buss, J. L., Neuzil, J., Gellert, N., Weber, C., & Ponka, P. (2003). Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(02)01512-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.